Jim Morrissey

Jim Morrissey is an accomplished executive in the pharmaceutical marketing sector with extensive experience in leading marketing initiatives across various therapeutic areas. Currently serving as Executive Director and Head of Immunology Marketing at Mallinckrodt Pharmaceuticals, Jim Morrissey oversees a revenue-generating team responsible for the marketing of Acthar, which spans multiple disease states. Prior roles include Senior Director of Marketing for Autoimmune and Rare Disease at Mallinckrodt, where significant revenue contributions were achieved, and Senior Director of Marketing at Depomed, managing a portfolio of products that accounted for 40% of company sales. Jim Morrissey has a strong background in directing high-performing teams and implementing successful marketing strategies, demonstrated during a tenure with GSK that included overseeing a $450M segment and a successful brand turnaround for Paxil. Educational credentials include an MBA from Georgetown University and a Bachelor of Science in Finance from Seton Hall University.